{"pageContent": "Background and purpose: Criteria for determining the durability of the response to transrectal high-intensity focused ultrasound (HIFU) ablation of prostate cancer have been established by calculating progression-free probability.", "metaData": {"source": "Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years\nhttps://pubmed.ncbi.nlm.nih.gov/33196540/"}}